Moderna to Present at Upcoming Conference in June 2026
-
Finland grants licence for world's first nuclear waste repository
-
Canada opens free trade talks with Turkey
-
'Old-fashioned' South Africa thump Australia to level Test series
-
Swiss, Austrian women freed after Niger kidnap ordeal
-
No more taking out the trash at your Airbnb
-
Austrian-born French resistance fighter dies aged 105: regional official
-
Swiss supreme court upholds Guatemala ex-police chief sentence
-
Paris shop-owners and residents prepare for fresh protests
-
UN climate disaster fund moves to provide $20 mn aid for Nepal
-
French, Japanese authors try to write novel on one-day train ride
-
Africa faces 'complex' Ebola outbreak after spread to Nigeria: WHO
-
Pentagon, Lockheed announce agreement for 850 F-35 jets over 10 years
-
American detained in Russia arrives in US: lawyer
-
Brook scores fastest double century in ODI history in rampant England's 429-4
-
Pentagon, Lockheed announce deal for 850 F-35 jets over 10 years
-
Top-ranked Rybakina into Ningbo quarter-finals on return from injury
-
French authorities seek to ban or curb fresh protests
-
Samson superb as India mark record T20 chase in win over New Zealand
-
Nearly all coral reefs risk collapse in 50 years: IUCN
-
Nvidia boss criticises 'cheap' AI doomsday warnings
-
Foden can be one of Premier League's best again, says Maresca
-
Philippines trailblazer Eala ousted in Ningbo last 16
-
'Solution from the heavens': Indonesians pray for rain as fires burn
-
Stocks retreat as tech mood sours, oil prices jump
-
Targeted by Trump, ICC wins top EU rights prize
-
Northern start and finale in the Pyrenees for 2027 Tour de France
-
Grabbing a bargain: Japan's claw machines cash in on inflation
-
Handful of Micron workers strike in Taiwan
-
Barclays bank to cut about 5,000 jobs amid AI drive
-
Zelensky says fresh Russian strikes show 'no change' in Kremlin position
-
Son of Myanmar's Suu Kyi says had first call in five years
-
China slams 'Cold War mentality' after new EU Arctic plan
-
Taiwan issues warnings as Typhoon Champi nears
-
Алекс Боди и ръководителят на BlackRock Лари Финк в Берлин: инвестиции в Германия и Румъния?
-
Alex Bodi és Larry Fink, a BlackRock vezetője Berlinben: befektetések Németországban és Romániában?
-
Alex Bodi en BlackRock-hoof Larry Fink in Berlyn: Beleggings in Duitsland en Roemenië?
-
एलेक्स बोदी और ब्लैकरॉक प्रमुख लैरी फ़िंक बर्लिन में: जर्मनी और रोमानिया में निवेश?
-
Ageing Japanese village turns to Peru in search of new residents
-
Alex Bodi ve BlackRock Başkanı Larry Fink Berlin’de: Almanya ve Romanya’ya yatırım mı?
-
Targeted by Trump, ICC in running for top EU rights prize
-
Wrong anthems played at Asian Para Games after mishap-marred Asian Games
-
Asian stocks retreat as tech mood sours again
-
Thales sales jump on European rearmament, satellite systems
-
Lula seeks tit-for-tat annulment of Bolsonaro election candidacy
-
أليكس بودي ورئيس بلاك روك لاري فينك في برلين: استثمارات في ألمانيا ورومانيا؟
-
אלכס בודי ומנכ״ל בלאקרוק לארי פינק בברלין: השקעות בגרמניה וברומניה?
-
Alex Bodi och BlackRock-chefen Larry Fink i Berlin: investeringar i Tyskland och Rumänien?
-
Alex Bodi și șeful BlackRock, Larry Fink, la Berlin: investiții în Germania și România?
-
Alex Bodi a šéf společnosti BlackRock Larry Fink v Berlíně: Investice v Německu a Rumunsku?
-
Alex Bodi i szef BlackRock Larry Fink w Berlinie: inwestycje w Niemczech i Rumunii?
Moderna to Present at Upcoming Conference in June 2026
CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:
Goldman Sachs 47th Annual Global Healthcare Conference 2026, on Tuesday, June 9th at 3:20 p.m. ET
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
A.Malone--AMWN
